325 related articles for article (PubMed ID: 12631267)
1. Modeled ligand-protein complexes elucidate the origin of substrate specificity and provide insight into catalytic mechanisms of phenylalanine hydroxylase and tyrosine hydroxylase.
Maass A; Scholz J; Moser A
Eur J Biochem; 2003 Mar; 270(6):1065-75. PubMed ID: 12631267
[TBL] [Abstract][Full Text] [Related]
2. Specific interaction of the diastereomers 7(R)- and 7(S)-tetrahydrobiopterin with phenylalanine hydroxylase: implications for understanding primapterinuria and vitiligo.
Pey AL; Martinez A; Charubala R; Maitland DJ; Teigen K; Calvo A; Pfleiderer W; Wood JM; Schallreuter KU
FASEB J; 2006 Oct; 20(12):2130-2. PubMed ID: 16935936
[TBL] [Abstract][Full Text] [Related]
3. Tetrahydrobiopterin binding to aromatic amino acid hydroxylases. Ligand recognition and specificity.
Teigen K; Dao KK; McKinney JA; Gorren AC; Mayer B; Frøystein NA; Haavik J; Martínez A
J Med Chem; 2004 Nov; 47(24):5962-71. PubMed ID: 15537351
[TBL] [Abstract][Full Text] [Related]
4. The structural basis of the recognition of phenylalanine and pterin cofactors by phenylalanine hydroxylase: implications for the catalytic mechanism.
Teigen K; Frøystein NA; Martínez A
J Mol Biol; 1999 Dec; 294(3):807-23. PubMed ID: 10610798
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of tyrosine hydroxylase with bound cofactor analogue and iron at 2.3 A resolution: self-hydroxylation of Phe300 and the pterin-binding site.
Goodwill KE; Sabatier C; Stevens RC
Biochemistry; 1998 Sep; 37(39):13437-45. PubMed ID: 9753429
[TBL] [Abstract][Full Text] [Related]
6. High resolution crystal structures of the catalytic domain of human phenylalanine hydroxylase in its catalytically active Fe(II) form and binary complex with tetrahydrobiopterin.
Andersen OA; Flatmark T; Hough E
J Mol Biol; 2001 Nov; 314(2):279-91. PubMed ID: 11718561
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Chaperones that Protect Tetrahydrobiopterin Dependent Aromatic Amino Acid Hydroxylases Through Different Mechanisms.
Hole M; Jorge-Finnigan A; Underhaug J; Teigen K; Martinez A
Curr Drug Targets; 2016; 17(13):1515-26. PubMed ID: 26953246
[TBL] [Abstract][Full Text] [Related]
8. Reversing the substrate specificities of phenylalanine and tyrosine hydroxylase: aspartate 425 of tyrosine hydroxylase is essential for L-DOPA formation.
Daubner SC; Melendez J; Fitzpatrick PF
Biochemistry; 2000 Aug; 39(32):9652-61. PubMed ID: 10933781
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydrobiopterin treatment reduces brain L-Phe but only partially improves serotonin in hyperphenylalaninemic ENU1/2 mice.
Scherer T; Allegri G; Sarkissian CN; Ying M; Grisch-Chan HM; Rassi A; Winn SR; Harding CO; Martinez A; Thöny B
J Inherit Metab Dis; 2018 Jul; 41(4):709-718. PubMed ID: 29520738
[TBL] [Abstract][Full Text] [Related]
10. Interaction energies between tetrahydrobiopterin analogues and aromatic residues in tyrosine hydroxylase and phenylalanine hydroxylase.
Hofto ME; Cross JN; Cafiero M
J Phys Chem B; 2007 Aug; 111(32):9651-4. PubMed ID: 17658743
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the ternary complex of the catalytic domain of human phenylalanine hydroxylase with tetrahydrobiopterin and 3-(2-thienyl)-L-alanine, and its implications for the mechanism of catalysis and substrate activation.
Andersen OA; Flatmark T; Hough E
J Mol Biol; 2002 Jul; 320(5):1095-108. PubMed ID: 12126628
[TBL] [Abstract][Full Text] [Related]
12. "7-tetrahydrobiopterin," a naturally occurring analogue of tetrahydrobiopterin, is a cofactor for and a potential inhibitor of the aromatic amino acid hydroxylases.
Davis MD; Ribeiro P; Tipper J; Kaufman S
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10109-13. PubMed ID: 1359535
[TBL] [Abstract][Full Text] [Related]
13. A specific tetrahydrobiopterin binding domain on tyrosinase controls melanogenesis.
Wood JM; Schallreuter-Wood KU; Lindsey NJ; Callaghan S; Gardner ML
Biochem Biophys Res Commun; 1995 Jan; 206(2):480-5. PubMed ID: 7826365
[TBL] [Abstract][Full Text] [Related]
14. Probing cofactor specificity in phenylalanine hydroxylase by molecular dynamics simulations.
Teigen K; Martinez A
J Biomol Struct Dyn; 2003 Jun; 20(6):733-40. PubMed ID: 12744702
[TBL] [Abstract][Full Text] [Related]
15. Dopamine-releasing action of 6R-L-erythro-tetrahydrobiopterin: analysis of its action site using sepiapterin.
Koshimura K; Miwa S; Watanabe Y
J Neurochem; 1994 Aug; 63(2):649-54. PubMed ID: 7518501
[TBL] [Abstract][Full Text] [Related]
16. Conformation of the substrate and pterin cofactor bound to human tryptophan hydroxylase. Important role of Phe313 in substrate specificity.
McKinney J; Teigen K; Frøystein NA; Salaün C; Knappskog PM; Haavik J; Martínez A
Biochemistry; 2001 Dec; 40(51):15591-601. PubMed ID: 11747434
[TBL] [Abstract][Full Text] [Related]
17. Changes in the cofactor binding domain of bovine striatal tyrosine hydroxylase at physiological pH upon cAMP-dependent phosphorylation mapped with tetrahydrobiopterin analogues.
Bailey SW; Dillard SB; Thomas KB; Ayling JE
Biochemistry; 1989 Jan; 28(2):494-504. PubMed ID: 2565733
[TBL] [Abstract][Full Text] [Related]
18. The effect of substrate, dihydrobiopterin, and dopamine on the EPR spectroscopic properties and the midpoint potential of the catalytic iron in recombinant human phenylalanine hydroxylase.
Hagedoorn PL; Schmidt PP; Andersson KK; Hagen WR; Flatmark T; Martínez A
J Biol Chem; 2001 Jun; 276(25):22850-6. PubMed ID: 11301319
[TBL] [Abstract][Full Text] [Related]
19. Characterization of chimeric pterin-dependent hydroxylases: contributions of the regulatory domains of tyrosine and phenylalanine hydroxylase to substrate specificity.
Daubner SC; Hillas PJ; Fitzpatrick PF
Biochemistry; 1997 Sep; 36(39):11574-82. PubMed ID: 9305947
[TBL] [Abstract][Full Text] [Related]
20. Coordinate regulation of tetrahydrobiopterin turnover and phenylalanine hydroxylase activity in rat liver cells.
Mitnaul LJ; Shiman R
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):885-9. PubMed ID: 7846072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
